Ocugen (OCGN) Current Leases (2014 - 2026)
Ocugen (OCGN) reported Current Leases of $850000.0 for Q1 2026, up 15.49% on a YoY basis from $736000.0 in Q1 2025, and down 0.93% quarter-over-quarter from $858000.0 in Q4 2025.
Ocugen (OCGN) Current Leases (2014 - 2026) Analysis & Trends
Ocugen has reported Current Leases for 12 years, with the latest figure at $850000.0 in Q1 2026.
- For the quarter ending Q1 2026, Current Leases rose 15.49% year-over-year to $850000.0; the trailing twelve-month figure through Mar 2026 stood at $850000.0 (up 15.49% YoY), and the FY2025 full-year result was $858000.0, up 65.32% from the prior year.
- Current Leases for Q1 2026 stood at $850000.0, down from $858000.0 in the prior quarter.
- The five-year high for Current Leases was $858000.0 in Q4 2025, with the low at $254000.0 in Q1 2022.
- Historically, Current Leases has averaged $579941.2 across 5 years, with a median of $526000.0 in 2023.
- Annual changes were most pronounced in 2022 — Current Leases soared 157.56% — and 2024, when it fell 12.36%.
- Ocugen's Current Leases stood at $498000.0 in 2022, then climbed by 15.26% to $574000.0 in 2023, then dropped by 9.58% to $519000.0 in 2024, then soared by 65.32% to $858000.0 in 2025, then decreased by 0.93% to $850000.0 in 2026.
- The last three Current Leases figures came in at $850000.0 (Q1 2026), $858000.0 (Q4 2025), and $855000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | 850,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 850,000.00 |
| Dec 31, 2025 | 858,000.00 |
| Sep 30, 2025 | 855,000.00 |
| Jun 30, 2025 | 853,000.00 |
| Mar 31, 2025 | 736,000.00 |
| Dec 31, 2024 | 519,000.00 |
| Sep 30, 2024 | 477,000.00 |
| Jun 30, 2024 | 461,000.00 |
| Mar 31, 2024 | 589,000.00 |
| Dec 31, 2023 | 574,000.00 |
| Sep 30, 2023 | 540,000.00 |
| Jun 30, 2023 | 526,000.00 |
| Mar 31, 2023 | 512,000.00 |
| Dec 31, 2022 | 498,000.00 |
| Sep 30, 2022 | 443,000.00 |
| Jun 30, 2022 | 314,000.00 |
| Mar 31, 2022 | 254,000.00 |
| Dec 31, 2021 | 363,000.00 |
| Sep 30, 2021 | 172,000.00 |
| Jun 30, 2021 | 168,000.00 |